Kwangrok Jung Selected Research

Oxaliplatin (Eloxatin)

1/2021

Gender Differences in Patients with Metastatic Pancreatic Cancer Who Received FOLFIRINOX.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kwangrok Jung Research Topics

Disease

2	Pancreatic Neoplasms (Pancreatic Cancer) 06/2022 - 01/2021
1	Biliary Tract Neoplasms (Biliary Tract Cancer) 01/2022
1	Neutropenia 01/2022
1	Hepatitis 03/2019
1	Jaundice (Icterus) 03/2019
1	Diarrhea 03/2019
1	Myalgia 03/2019
1	Fever (Fevers) 03/2019
1	Acute Liver Failure (Fulminant Hepatic Failure) 03/2019

Drug/Important Bio-Agent (IBA)

1	130-nm albumin-bound paclitaxelIBA 01/2022
1	Gemcitabine FDA Link 01/2022
1	Cisplatin (Platino)FDA LinkGeneric 01/2022
1	folfirinoxIBA 01/2021
1	Irinotecan (Camptosar)FDA LinkGeneric 01/2021
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2021
1	Leucovorin (Folinic Acid)FDA Link 01/2021
1	Fluorouracil (Carac)FDA LinkGeneric 01/2021
1	Halothane HepatitisIBA 03/2019
1	2,2-dichloro-1,1,1-trifluoroethane (HCFC 123)IBA 03/2019

Therapy/Procedure

1	Pancreatectomy 06/2022
1	Drug Therapy (Chemotherapy) 01/2022
1	Therapeutics 01/2021